États-Unis · Places boursières & cours · Nasdaq

PTC Therapeutics Board Approves $500 Mln Share Buyback

Publié par Nasdaq · États-Unis il y a 1 h

(RTTNews) - PTC Therapeutics, Inc. (PTCT), a biopharmaceutical company, said Tuesday that its Board of Directors has authorized a share repurchase program of up to $500 million.

Lire l'article complet sur Nasdaq Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.nasdaq.com)

PTC Therapeutics Board Approves $500 Mln Share Buyback

À lire aussi

Indian Refiner BPCL Buys U.S. WTI Crude Oil Cargo

Bitcoin ETF Tracker

What to know about the possibility of federal officers showing up at polling stations

Here’s How Much Traders Expect Palantir Stock to Move After Earnings

Nasdaq and S&P 500 Index Lose Momentum, Pull Down Market

Introducing new self-learning context enrichment in Knowledge Catalog

PTC Therapeutics Board Approves $500 Mln Share Buyback

Partager

À lire aussi

Indian Refiner BPCL Buys U.S. WTI Crude Oil Cargo

Bitcoin ETF Tracker

What to know about the possibility of federal officers showing up at polling stations

Here’s How Much Traders Expect Palantir Stock to Move After Earnings

Nasdaq and S&P 500 Index Lose Momentum, Pull Down Market

Introducing new self-learning context enrichment in Knowledge Catalog